ICOTF - iCo Therapeutics GAAP EPS of -$0.64 May, 02 2022 02:36 AM Ico Therapeutics Inc iCo Therapeutics press release (OTC:ICOTF): FY GAAP EPS of -$0.64. Satellos had cash and cash equivalents of $4.87M as at December 31, 2021. For further details see: iCo Therapeutics GAAP EPS of -$0.64